Last update:

Oncology & Cancer news

Oncology & Cancer

Weight-loss surgery may lower risk of pancreatic cancer in people with obesity

Obesity and type 2 diabetes are risk factors for various malignancies, including pancreatic cancer, which has a high death rate. A new analysis in Diabetes/Metabolism Research and Reviews suggests that weight-loss surgery—also ...

Oncology & Cancer

DAPK3 emerges as a new regulator of migration of triple-negative breast cancer cells

Triple-negative breast cancer (TNBC) is the subtype of breast cancer that is the hardest to treat. TNBC patients account for more than 20,000 cases of this condition annually in the U.S. alone. They experience worse outcomes ...

Oncology & Cancer

Cell line models identify cause of melanoma with drug resistance

Melanoma is a type of cancer that originates from melanocytes, the cells responsible for producing skin pigment, and is known as the most lethal form of skin cancer due to its high rates of metastasis and recurrence. With ...

Oncology & Cancer

Study explores novel therapeutic treatment for glioblastoma

Glioblastoma (GBM) is the most lethal brain tumor, with a median survival rate of merely 12-16 months after diagnosis. Despite surgical, radiation and chemotherapy treatments, the two-year survival rate for GBM patients is ...

Oncology & Cancer

Novel bioassay predicts cancer patients' response to immunotherapy

A team of researchers from Ben-Gurion University of the Negev (BGU) has developed a groundbreaking bio-sensing technology that predicts the response of cancer patients to anti-PD1, an immune checkpoint inhibitor (ICI) therapy, ...

Medical research

Tunable bonds: A step towards targeted At-211 cancer therapy

Astatine is the least abundant element on Earth, and all of its known isotopes have a half-life of less than 8 hours. One astatine isotope, astatine-211 (At-211), emits alpha particles and shows promise as a cancer therapy. ...

Medical research

Why new cancer treatment discoveries are proliferating

In the five years since the FDA's initial approval of chimeric antigen receptor (CAR) T cell therapy, Penn Medicine has gleaned 20 additional approvals related to drugs and techniques to treat or detect cancer.

Oncology & Cancer

Research team develops new system for imaging and treating tumors

Thanks to the radiation they emit, radioactive compounds are suited both to imaging and treating cancers. By appropriately combining them in novel, so-called radionuclide theranostics, both applications can be dovetailed. ...

Oncology & Cancer

Rethinking the protein inhibitor approach to cancer therapy

A new method than enables researchers to dial up or tone down the amount of a certain metastatic protein inhibitor (BACH1) within a cell could provide a new path in cancer research that reassesses the effectiveness of protein ...